TAS-102 Prolongs Survival in Phase III Gastric Cancer Study

Jun 21, 2018

TAS-102 (trifluridine/tipiracil; Lonsurf) provided a 31% reduction in the risk of death compared with placebo in patients with heavily pretreated metastatic or advanced gastric cancer, according to findings from the phase III TAGS study reported at the 2018 World Gastrointestinal Cancer Congress.

Read more


Endoscopic Surveillance Detects Early Gastric Cancer

by Diana Swift, Contributing Writer
June 16, 2018

Endoscopic surveillance can detect gastric cancer at an early curable stage, Dutch researchers reported in Gut.

Read more